166940-44-9

Basic information

• Product Name: Benzenemethanol, -alpha-,2,4-trimethyl-, (-alpha-R)- (9CI)
• Synonyms: Benzenemethanol, -alpha-,2,4-trimethyl-, (-alpha-R)- (9CI)
• CAS NO: 166940-44-9
• Molecular Formula: C10H14O
• Molecular Weight: 150.21756
• Product Categories: PHENYL
• Mol File: 166940-44-9.mol
• Article Data: 19

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Benzenemethanol, -alpha-,2,4-trimethyl-, (-alpha-R)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenemethanol, -alpha-,2,4-trimethyl-, (-alpha-R)- (9CI)(166940-44-9)
• EPA Substance Registry System: Benzenemethanol, -alpha-,2,4-trimethyl-, (-alpha-R)- (9CI)(166940-44-9)

Safety Data

• Hazardous Substances Data: 166940-44-9(Hazardous Substances Data)

Upstream product

• 102877-07-6 1-(2,4-dimethylphenyl)ethanamine 
• 89-74-7 2,4-dimethylacetophenone. 
• 7446-70-0 aluminium trichloride 
• 107-06-2 1,2-dichloro-ethane 
• 75-36-5 acetyl chloride 
• 108-38-3 m-xylene 
• 64-17-5 ethanol 
• 64-19-7 acetic acid 
• 2234-20-0 2,4-dimethylstyrene 
• 108-05-4 vinyl acetate 
• 99500-87-5 1-(2,4-dimethylphenyl)ethanol 
• 123-62-6 propionic acid anhydride 

Downstream Products

• 1613639-26-1 C₁₃H₁₈O₂ 
• 166940-44-9 (R)-1-(2,4-dimethylphenyl)ethan-1-ol 
• 20871-92-5 2-(bromoethyl)-5-methyltoluene 
• 14679-18-6 2-(o,p-Dimethylphenyl)-aethyl-n-butyl-sulfid 
• 168749-62-0 1-(2,4-Dimethyl-phenyl)-ethanol 
• 1019527-08-2 N-(1-(2,4-dimethylphenyl)ethyl)aniline 

Relevant articles and documents

-

-

Manganese-Catalyzed Enantioselective Hydrogenation of Simple Ketones Using an Imidazole-Based Chiral PNN Tridentate Ligand

A series of Mn(I) catalysts containing imidazole-based chiral PNN tridentate ligands with controllable 'side arm' groups have been established, enabling the inexpensive base-promoted asymmetric hydrogenation of simple ketones with outstanding activities (up to 8200 TON) and good enantioselectivities (up to 88.5percent ee). This protocol features wide substrate scope and functional group tolerance, thereby providing easy access to a key intermediate of crizotinib.

AZAINDOLE COMPOUNDS, SYNTHESIS THEREOF, AND METHODS OF USING THE SAME

The invention provides compounds of formula (I) and methods of treating a Mycobacterium infection or tuberculosis, or inhibiting DprE1 with the same.